TELA Bio (TELA) Operating Expenses (2018 - 2026)

TELA Bio has reported Operating Expenses for 9 years, with the latest figure at $23.2 million in Q2 2026.

• On a quarterly basis, Operating Expenses changed 0.17% year-over-year to $23.2 million in Q2 2026; TTM through Jun 2026 was $88.2 million, a 0.26% change from a year earlier, with the FY2025 full-year figure at $88.1 million, changed 0.1% from the prior year.
• Operating Expenses was $23.2 million for Q2 2026 at TELA Bio, up from $23.0 million in the prior quarter.
• The five-year high for Operating Expenses was $23.9 million in Q4 2023, with the low at $14.8 million in Q1 2022.
• Average Operating Expenses over 5 years is $20.7 million, with a median of $21.0 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Operating Expenses jumped 42.19% in 2022, then decreased 18.1% in 2024.
• Over 5 years, Operating Expenses stood at $17.6 million in 2022, then jumped by 35.69% to $23.9 million in 2023, then fell by 18.1% to $19.6 million in 2024, then grew by 4.23% to $20.4 million in 2025, then advanced by 13.84% to $23.2 million in 2026.
• The last three Operating Expenses figures came in at $23.2 million (Q2 2026), $23.0 million (Q1 2026), and $20.4 million (Q4 2025), per Business Quant data.